205 related articles for article (PubMed ID: 27911867)
1. Decreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysis.
Chen Z; Shi X; Guo L; Li Y; Luo M; He J
Oncotarget; 2017 Jan; 8(1):1944-1952. PubMed ID: 27911867
[TBL] [Abstract][Full Text] [Related]
2. Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma.
Shi X; Yu Y; Luo M; Zhang Z; Shi S; Feng X; Chen Z; He J
PLoS One; 2016; 11(4):e0153100. PubMed ID: 27050164
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of ten-eleven translocation genes in endometrial cancers.
Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
[TBL] [Abstract][Full Text] [Related]
4. Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.
Yang Q; Wu K; Ji M; Jin W; He N; Shi B; Hou P
J Biomed Nanotechnol; 2013 Sep; 9(9):1607-16. PubMed ID: 23980508
[TBL] [Abstract][Full Text] [Related]
5. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
Tsai KW; Li GC; Chen CH; Yeh MH; Huang JS; Tseng HH; Fu TY; Liou HH; Pan HW; Huang SF; Chen CC; Chang HY; Ger LP; Chang HT
Breast Cancer Res Treat; 2015 Aug; 153(1):219-34. PubMed ID: 26253945
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
Zhang LY; Li PL; Wang TZ; Zhang XC
Arch Gynecol Obstet; 2015 Oct; 292(4):891-7. PubMed ID: 25827305
[TBL] [Abstract][Full Text] [Related]
7. Preferential 5-Methylcytosine Oxidation in the Linker Region of Reconstituted Positioned Nucleosomes by Tet1 Protein.
Kizaki S; Zou T; Li Y; Han YW; Suzuki Y; Harada Y; Sugiyama H
Chemistry; 2016 Nov; 22(46):16598-16601. PubMed ID: 27689340
[TBL] [Abstract][Full Text] [Related]
8. Sensitive and simultaneous determination of 5-methylcytosine and its oxidation products in genomic DNA by chemical derivatization coupled with liquid chromatography-tandem mass spectrometry analysis.
Tang Y; Zheng SJ; Qi CB; Feng YQ; Yuan BF
Anal Chem; 2015 Mar; 87(6):3445-52. PubMed ID: 25675106
[TBL] [Abstract][Full Text] [Related]
9. 5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy.
Vasanthakumar A; Godley LA
Cancer Genet; 2015 May; 208(5):167-77. PubMed ID: 25892122
[TBL] [Abstract][Full Text] [Related]
10. Maintenance DNA Methyltransferase Activity in the Presence of Oxidized Forms of 5-Methylcytosine: Structural Basis for Ten Eleven Translocation-Mediated DNA Demethylation.
Seiler CL; Fernandez J; Koerperich Z; Andersen MP; Kotandeniya D; Nguyen ME; Sham YY; Tretyakova NY
Biochemistry; 2018 Oct; 57(42):6061-6069. PubMed ID: 30230311
[TBL] [Abstract][Full Text] [Related]
11. Ten-eleven translocase: key regulator of the methylation landscape in cancer.
Shekhawat J; Gauba K; Gupta S; Choudhury B; Purohit P; Sharma P; Banerjee M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1869-1879. PubMed ID: 33913031
[TBL] [Abstract][Full Text] [Related]
12. The clinical values of dysregulated DNA methylation and demethylation intermediates in acute lymphoblastic leukemia.
Cao LL; Liu H; Yue Z; Pei L; Wang H; Jia M
Hematology; 2019 Dec; 24(1):567-576. PubMed ID: 31315520
[No Abstract] [Full Text] [Related]
13. TET enzymatic oxidation of 5-methylcytosine, 5-hydroxymethylcytosine and 5-formylcytosine.
Cadet J; Wagner JR
Mutat Res Genet Toxicol Environ Mutagen; 2014 Apr; 764-765():18-35. PubMed ID: 24045206
[TBL] [Abstract][Full Text] [Related]
14. Mutations along a TET2 active site scaffold stall oxidation at 5-hydroxymethylcytosine.
Liu MY; Torabifard H; Crawford DJ; DeNizio JE; Cao XJ; Garcia BA; Cisneros GA; Kohli RM
Nat Chem Biol; 2017 Feb; 13(2):181-187. PubMed ID: 27918559
[TBL] [Abstract][Full Text] [Related]
15. Ten-eleven translocation proteins (TETs): tumor suppressors or tumor enhancers?
Ma C; Seong H; Liu Y; Yu X; Xu S; Li Y
Front Biosci (Landmark Ed); 2021 Oct; 26(10):895-915. PubMed ID: 34719214
[TBL] [Abstract][Full Text] [Related]
16. Oxidized C5-methyl cytosine bases in DNA: 5-Hydroxymethylcytosine; 5-formylcytosine; and 5-carboxycytosine.
Klungland A; Robertson AB
Free Radic Biol Med; 2017 Jun; 107():62-68. PubMed ID: 27890639
[TBL] [Abstract][Full Text] [Related]
17. Discrimination between 5-Hydroxymethylcytosine and 5-Methylcytosine in DNA via Selective Electrogenerated Chemiluminescence (ECL) Labeling.
Ma S; Sun H; Li Y; Qi H; Zheng J
Anal Chem; 2016 Oct; 88(20):9934-9940. PubMed ID: 27620533
[TBL] [Abstract][Full Text] [Related]
18. Functional impacts of 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosine at a single hemi-modified CpG dinucleotide in a gene promoter.
Kitsera N; Allgayer J; Parsa E; Geier N; Rossa M; Carell T; Khobta A
Nucleic Acids Res; 2017 Nov; 45(19):11033-11042. PubMed ID: 28977475
[TBL] [Abstract][Full Text] [Related]
19. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Lian CG; Xu Y; Ceol C; Wu F; Larson A; Dresser K; Xu W; Tan L; Hu Y; Zhan Q; Lee CW; Hu D; Lian BQ; Kleffel S; Yang Y; Neiswender J; Khorasani AJ; Fang R; Lezcano C; Duncan LM; Scolyer RA; Thompson JF; Kakavand H; Houvras Y; Zon LI; Mihm MC; Kaiser UB; Schatton T; Woda BA; Murphy GF; Shi YG
Cell; 2012 Sep; 150(6):1135-46. PubMed ID: 22980977
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates.
Globisch D; Münzel M; Müller M; Michalakis S; Wagner M; Koch S; Brückl T; Biel M; Carell T
PLoS One; 2010 Dec; 5(12):e15367. PubMed ID: 21203455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
